Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

83 articles from the last 30 days

ResearchPUBMEDMar 28

Macrophage Extracellular Vesicles: Therapeutic Strategies for Corneal Fibrosis in Rare Diseases.

Scientists are studying a new way to treat corneal scarring (clouding of the eye that causes blindness) using tiny particles called extracellular vesicles that come from immune cells called macrophages. This approach is being tested for rare genetic eye diseases like epidermolysis bullosa, KID syndrome, and aniridia, where the cornea becomes scarred due to chronic inflammation and genetic mutations. Current treatments don't work well and have significant side effects, so this new method could offer patients a better option.

WHY IT MATTERSFor patients with epidermolysis bullosa, KID syndrome, or aniridia experiencing corneal scarring, this research offers a potential new treatment strategy that could prevent blindness without the side effects of current therapies.
Good to knowepidermolysis bullosakeratitis-ichthyosis-deafness syndromeaniridiaRead →
ResearchPUBMEDMar 28

From Genomic Diagnosis to Personalized RNA Medicine: Advances in Next-Generation Sequencing and N-of-1 Antisense Oligonucleotide Therapies for Rare Genetic Diseases.

Scientists are getting better at finding rare genetic diseases using a tool called next-generation sequencing, which can read a person's DNA quickly and accurately. They're also developing new medicines called antisense oligonucleotides that can be customized for each patient to fix problems caused by genetic mutations. Together, these advances mean doctors can diagnose rare diseases faster and create personalized treatments tailored to each person's specific genetic makeup.

WHY IT MATTERSThis research shows a clear path for patients with rare genetic diseases to move from diagnosis to personalized treatment within a single medical framework, potentially reducing the diagnostic odyssey that currently takes years for many rare disease patients.
Good to knowrare monogenic disordersrare genetic diseasesRead →
ResearchPUBMEDMar 28

Rare and emerging arterial diseases of the supra-aortic trunks: Diagnostic and therapeutic insights.

This article discusses rare diseases that affect the major blood vessels in the neck and upper chest (called supra-aortic trunks). While most blockages in these vessels are caused by common heart disease risk factors, about 10% happen in people without those risk factors. The article highlights three newly recognized conditions: TIPIC syndrome (temporary inflammation around the carotid artery), carotid web (an unusual narrowing), and Eagle syndrome (a bone growth problem). Better imaging technology is helping doctors identify these rare conditions more accurately.

WHY IT MATTERSIf you have unexplained neck pain, stroke symptoms, or carotid artery narrowing without typical heart disease risk factors, your doctor may now consider these emerging diagnoses instead of assuming standard atherosclerosis.
💬 Ask your doctorTransient Perivascular Inflammation of the Carotid artery (TIPIC) syndromeCarotid webEagle syndromeRead →
← PreviousPage 5 of 5

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases